I read this excellent post The Irrational Rationing of Health Care on LinkedIn by David Katz, that documents a case of denial of a treatment option to a patient because the payer considers that ‘not established as standard therapy for that cancer’ – as documented in their business criteria. As you would have guessed that the treatment option is a reasonably expensive one. This is an excellent article and an exemplary case for what I elaborate in previous blogs http://bit.ly/ACOSteadyState and http://bit.ly/sustainablehealthcare .
Continue reading How do we prevent denial of available and deserved therapeutic options to patients?
Do you know one of the advantages of being an engineer turned biotechnologist turned entrepreneur/capitalist? You can write a blog like the one below.
A few months ago, I was in an event that discussed approaches and challenges in tackling Ebola, organized by the MIT Enterprise Forum of Cambridge.
Continue reading Just in time (JIT) vaccines and cures for Ebola and other sporadically emerging (and devastating) global infectious diseases